BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23882933)

  • 1. [The use of hemostatic agent Tachosil in surgical treatment of kidney cancer infiltrating liver--case report].
    Drewniak T; Rzepecki M; Juszczak K; Jakubowski J; Sandheim M; Maciukiewicz P
    Pol Merkur Lekarski; 2013 Jun; 34(204):345-7. PubMed ID: 23882933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations.
    Mele E; Ceccanti S; Schiavetti A; Bosco S; Masselli G; Cozzi DA
    J Pediatr Surg; 2013 Mar; 48(3):689-94. PubMed ID: 23480936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sealing of gastrointestinal anastomoses with fibrin glue coated collagen patch.
    Nordentoft T
    Dan Med J; 2015 May; 62(5):. PubMed ID: 26050838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seal properties of TachoSil: in vitro hemodynamic measurements.
    Berdajs D; Bürki M; Michelis A; von Segesser LK
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):910-3. PubMed ID: 20354036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.
    Siemer S; Lahme S; Altziebler S; Machtens S; Strohmaier W; Wechsel HW; Goebell P; Schmeller N; Oberneder R; Stolzenburg JU; Becker H; Lüftenegger W; Tetens V; Van Poppel H
    Eur Urol; 2007 Oct; 52(4):1156-63. PubMed ID: 17467884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of TachoSil® versus standard treatment of air leakage after pulmonary lobectomy.
    Marta GM; Facciolo F; Ladegaard L; Dienemann H; Csekeo A; Rea F; Dango S; Spaggiari L; Tetens V; Klepetko W
    Eur J Cardiothorac Surg; 2010 Dec; 38(6):683-9. PubMed ID: 20541949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial.
    Maisano F; Kjaergård HK; Bauernschmitt R; Pavie A; Rábago G; Laskar M; Marstein JP; Falk V
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):708-14. PubMed ID: 19595605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemostatic effectiveness of TachoSil® patches in radiofrequency assisted minor hepatic resection].
    Sandonato L; Cipolla C; Airò Farulla C; Graceffa G; Giannitrapani L; Galia M; Lombardo G; Ferro G; Lodato L; Latteri MA
    Minerva Chir; 2010 Dec; 65(6):627-33. PubMed ID: 21224797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular carcinoma associated with cirrhosis of the liver.
    Sakon M; Monden M; Gotoh M; Kobayashi K; Kambayashi J; Mori T; Okamura J
    Surg Gynecol Obstet; 1989 May; 168(5):453-4. PubMed ID: 2469132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observations on the use of TachoSil® in cholecystectomy - a multicentre, prospective, single-arm cohort study].
    Schopf SK; von Ahnen M; von Ahnen T; Schardey HM
    Zentralbl Chir; 2012 Feb; 137(1):55-60. PubMed ID: 22344836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Tachosil® in bariatric surgery: preliminary experience in control of bleeding after sleeve gastrectomy.
    Pilone V; Di Micco R; Monda A; Villamaina E; Forestieri P
    Minerva Chir; 2012 Jun; 67(3):241-8. PubMed ID: 22691828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postexplant residual cavity hemostasis with a TachoSil patch.
    De Rosa P; Valeriani G; Barbato G; Cerbone V; Ciccone M; Russo E; Vicedomini D
    Transplant Proc; 2011 May; 43(4):1069-71. PubMed ID: 21620055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs.
    Erdogan D; de Graaf W; van Gulik TM
    Eur Surg Res; 2008; 41(3):298-302. PubMed ID: 18797168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study.
    Toti L; Attia M; Manzia TM; Lenci I; Gunson B; Buckels JA; Mirza DF; Mayer AD; Bramhall SR; Wigmore SJ
    Dig Liver Dis; 2010 Mar; 42(3):205-9. PubMed ID: 19913466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TachoSil(®) sealed tubeless percutaneous nephrolithotomy to reduce urine leakage and bleeding: outcome of a randomized controlled study.
    Cormio L; Perrone A; Di Fino G; Ruocco N; De Siati M; de la Rosette J; Carrieri G
    J Urol; 2012 Jul; 188(1):145-50. PubMed ID: 22591964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of the effectiveness of Tachosil in the treatment of lymphorrhea of the postoperative wound in the selected group of patients, after vascular reconstructive surgeries--preliminary report.
    Iłżecki M; Zubilewicz T; Przywara S; Terlecki P
    Pol Przegl Chir; 2013 Dec; 85(12):687-92. PubMed ID: 24468588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial Comment on: Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.
    Sagalowsky AI
    Eur Urol; 2007 Oct; 52(4):1162-3. PubMed ID: 17467888
    [No Abstract]   [Full Text] [Related]  

  • 18. The application of TachoSil® for sealing colorectal anastomosis: a feasibility study.
    Parker MC; Pohlen U; Borel Rinkes IH; Delvin T
    Colorectal Dis; 2013 Feb; 15(2):252-7. PubMed ID: 22731706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic and outcomes consequences of TachoSil®: a systematic review.
    Colombo GL; Bettoni D; Di Matteo S; Grumi C; Molon C; Spinelli D; Mauro G; Tarozzo A; Bruno GM
    Vasc Health Risk Manag; 2014; 10():569-75. PubMed ID: 25246797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial.
    Fischer L; Seiler CM; Broelsch CE; de Hemptinne B; Klempnauer J; Mischinger HJ; Gassel HJ; Rokkjaer M; Schauer R; Larsen PN; Tetens V; Büchler MW
    Surgery; 2011 Jan; 149(1):48-55. PubMed ID: 20385397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.